Cargando…
Disease Severity Assessment and Short-Term Outcome in Patients with Myasthenia Gravis
BACKGROUND: Myasthenia gravis (MG) is an autoimmune disorder with a chronic fluctuating course. The outcome measures encapsulate disease severity, functional impact at diagnosis, and objective evaluation of clinical benefit from therapeutic interventions. AIMS AND OBJECTIVE: To assess the disease se...
Autores principales: | Vemuri, Deepthi, Garuda, Butchi Raju, Gopi, S., Kumar, T. Sateesh, Kumari, U. Aruna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061515/ https://www.ncbi.nlm.nih.gov/pubmed/32189865 http://dx.doi.org/10.4103/aian.AIAN_243_19 |
Ejemplares similares
-
Sensitivity of MG‐ADL for generalized weakness in myasthenia gravis
por: de Meel, R. H. P., et al.
Publicado: (2018) -
Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901) -
Clinical Features and Prognosis of Ocular Myasthenia Gravis Patients with Different Phenotypes
por: Wang, Li-Li, et al.
Publicado: (2015) -
Description of 3 patients with myasthenia gravis and COVID-19
por: Rein, Netaniel, et al.
Publicado: (2020) -
Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study
por: McPherson, Tarrant, et al.
Publicado: (2020)